81217 Brca2 gene known famil vrnt
Also known as: BRCA2 familial variant testing, BRCA2 targeted analysis
Targeted mutation analysis of the BRCA2 gene to identify known familial variants associated with hereditary breast and ovarian cancer.
In Plain Language
breast cancer gene test; family mutation detection
Clinical Context
Used to identify known BRCA2 pathogenic variants in family members of affected individuals for genetic counseling and surveillance planning.
RVU Information
CPT 81217 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81217?
CPT 81217 (Brca2 gene known famil vrnt) is a Pathology & Lab code. Targeted mutation analysis of the BRCA2 gene to identify known familial variants associated with hereditary breast and ovarian cancer.
Who uses CPT code 81217?
CPT 81217 is used by Oncology, Genetics, Pathology. Used to identify known BRCA2 pathogenic variants in family members of affected individuals for genetic counseling and surveillance planning.
When is CPT 81217 used?
Used to identify known BRCA2 pathogenic variants in family members of affected individuals for genetic counseling and surveillance planning.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.